The vector of anti-HER2 T cell receptor (TCR) is constructed for the engineering of T cell to target Human HER2. The T cells are genetically modified through transduction with a retroviral vector expressing HER2-specific T cell receptor. And the vector product was designed for the treatment of breast cancers.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|TCR-L230||Human anti-Her2 T cell receptor (H3), pCDTCR1|
|VP-TCR-C134||Lenti-Her2 T cell receptor (E1) Viral Particle|
|CAR-MZ132||Anti-ErbB2 (L96) h(CD28-CD3ζ) CAR, pCDCAR1|
|VP-CAR-LC748||Lenti-ErbB2 CAR (scFv-CD28-CD3ζ, Trastuzumab) Viral Particle|
|TCR-C098Z||Murinized anti-HER2 T cell receptor (HER2-2), pCDTCR1|
|OAdCmodV-YX1022||Oncolytic Adenovirus (Capsid modified Ad5, phTERT-Δ19k, Anti-ERBB2-3), Viral particle|
|CAR-NK-2-M331-4G||Anti-ErbB2 scFv h(CD4-FcεRIγ) CARNK, pCDCAR1|
|CAR-T-1-M550-2||Anti-HER2 VHH h(CD28) CAR, [T]|
|CAR-NK-1-M331-Z||Anti-ErbB2 scFv h(CD3ζ) CARNK, pCDCAR1|
|OAdCmodV-YX1008||Oncolytic Adenovirus (Capsid modified Ad5, phTERT-Δ24/19k, Anti-ERBB2-1), Viral particle|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved